These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 604122)

  • 41. [Antigenic structure of the neuraminidases of vaccinal strains of influenza virus type A used in the production of live anti-influenza oral vaccine].
    Mel'nikova SK; Aleksandrova AN; Alekseeva AK
    Vopr Virusol; 1976; (3):287-9. PubMed ID: 62454
    [No Abstract]   [Full Text] [Related]  

  • 42. A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity.
    Brady MI; Furminger IG
    J Hyg (Lond); 1976 Oct; 77(2):173-80. PubMed ID: 1068196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine.
    Hinshaw VS; Bean WJ; Webster RG; Easterday BC
    Virology; 1978 Jan; 84(1):51-62. PubMed ID: 74123
    [No Abstract]   [Full Text] [Related]  

  • 44. Direct solid-phase radioimmunoassay for measuring antigenic differences between the hemagglutinins of influenza viruses.
    Russell RJ; Jackson DC
    J Immunol Methods; 1978; 22(3-4):201-9. PubMed ID: 79617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Postgrad Med J; 1976 Jun; 52(608):373-8. PubMed ID: 785428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An adsorbed surface-antigen influenza vaccine and its serological activity in volunteers.
    Brady MI; Furminger IG; Stones PB
    Postgrad Med J; 1976 Jun; 52(608):368-72. PubMed ID: 785427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody response in humans after administration of whole-virion and split vaccine prepared from two different influenza A/swine viruses.
    Závadová H; Vonka V; Domorázková E; Syrůcek L; Stárek M; Hrusková J; Plesník V; Janout V; Uvízl M
    Dev Biol Stand; 1977 Jun 1-3; 39():231-4. PubMed ID: 604101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuraminidase antibodies in serum and nasal washings after immunization by means of live and killed whole virion, split virion and subunit (HA and N) influenza vaccines.
    Kuwert EK; Höher PG; Werner J; Scheiermann N; Thraenhart O; Müller B; Kleber G
    Dev Biol Stand; 1977 Jun 1-3; 39():77-83. PubMed ID: 604137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody formation in laboratory animals after parenteral application of A/swine influenza virus.
    Dolezalová B; Závadová H; Stárek M; Vonka V
    Dev Biol Stand; 1977 Jun 1-3; 39():405-8. PubMed ID: 604122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
    Tamura S; Tanimoto T; Kurata T
    Jpn J Infect Dis; 2005 Aug; 58(4):195-207. PubMed ID: 16116250
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.